Suchergebnisse - "Emadi, Ashkan"

PubPharm (175)

11

Cancer Pharmacology : An Illustrated Manual of Anticancer Drugs

Erschienen: New York, Springer Publishing Company, Incorporated, 2023

2nd ed.

von Emadi, A. | Karp, J.

12

Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation

enthalten in: Molecular Carcinogenesis | 2023

von Adhikary, G. | Shrestha, S. | Naselsky, W. | +6

13

Durable response to ivosidenib in post-transplant relapse and leukemic transformation of myelodysplastic syndrome with new complex karyotype and IDH1 R132C mutation

enthalten in: Leukemia & lymphoma | 2022

von Alkhaldi, H. | Sewell, D. | Ning, Y. | +4

14

Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von O'Connell, C. | Baer, M. | Ørskov, A. | +20

15

Aziridinyl and amino dimeric naphthoquinone compounds and use for acute myeloid leukemia

enthalten in: Europäisches Patentamt | 2022

von EMADI ASHKAN | LAPIDUS RENA G | CARTER-COOPER BRANDON A | +3

16

Arsenic trioxide dose capping to decrease toxicity in the treatment of acute promyelocytic leukemia

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2022

von Zacholski, K. | Hambley, B. | Hickey, E. | +13

17

Impact of FLT3-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia : A Propensity Score-Adjusted Cohort Study

enthalten in: Biology | 2022

von Corley, E. | Mustafa Ali, M. | Alharthy, H. | +8

18

Translatome changes in acute myeloid leukemia cells post exposure to pegcrisantaspase and venetoclax

enthalten in: Experimental hematology | 2022

von Kapadia, B. | Shetty, A. | Bollino, D. | +7

19

Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Baer, M. | Kogan, A. | Bentzen, S. | +9

20

ASPARAGINASE-INDUCED GLUTAMINE DEPLETION COMBINED WITH BCL-2 INHIBITION FOR TREATMENT OF HEMATOLOGIC AND SOLID CANCERS

enthalten in: Europäisches Patentamt | 2022

von EMADI ASHKAN | LAPIDUS RENA G